| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |